PTC Therapeutics Inc.
PTCT | NASDAQ
$65.26
-$0.11 (-0.17%)
At close: Sep 21, 2026, 4:00 PM ET
$73.01
+$7.75 (+11.88%)
Pre-market:
Sep 22, 2026, 8:45 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 360.52M | 272.55M | 164.68M | 211.01M | 178.88M | 1.18B | 213.17M | 196.79M | 186.7M | 210.12M | 307.06M | 196.58M | 213.81M | 220.38M | 167.41M | 217.13M | 165.53M | 148.74M | 165.23M | 138.74M | 116.68M | 117.94M |
Cost of Revenue | n/a | 39.61M | 16.3M | 115.94M | 11.42M | 12.86M | 16.28M | 10.85M | 15.53M | 14.74M | 106.29M | 9.49M | 12.73M | 14.14M | 10.89M | 14.01M | 9.64M | 10.14M | 9.33M | 6.54M | 7.36M | 9.1M |
Gross Profit | n/a | 232.94M | 148.38M | 95.07M | 167.46M | 1.16B | 196.89M | 185.94M | 171.18M | 195.38M | 200.76M | 187.08M | 201.08M | 206.24M | 156.52M | 203.12M | 155.89M | 138.6M | 155.9M | 132.2M | 109.32M | 108.84M |
Operating Income | 148.98M | 45.89M | -81.62M | 3.02M | -34.96M | 970.23M | -162.39M | -54.51M | -40.22M | -45.45M | 3.12M | -118.16M | -209.54M | -117.62M | -200.34M | -73.49M | -92.36M | -86.52M | -84.73M | -93.08M | -98.49M | -98.15M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 97.55M | -2.46M | -139.08M | -23.07M | -71.05M | 929.83M | -94.7M | -97.99M | -85.73M | -84.7M | -157.05M | -166.59M | -237.48M | -134.99M | -189.69M | -127.21M | -148.7M | -121.89M | -138.61M | -133.66M | -117.88M | -128.19M |
Net Income | 83.5M | -2.81M | -134.97M | 15.9M | -64.85M | 866.56M | -65.89M | -106.65M | -99.18M | -91.58M | -155.79M | -132.97M | -198.88M | -138.96M | -170.89M | -109.32M | -152.09M | -126.73M | -143.27M | -133.62M | -118.37M | -128.64M |
Selling & General & Admin | 80.63M | 86.18M | 100.47M | 84.05M | 85.26M | 80.96M | 84.68M | 73.46M | 69.5M | 73.27M | 76.29M | 80.89M | 88.45M | 86.91M | 92.72M | 80.12M | 79.89M | 73.27M | 86.55M | 69.25M | 68.88M | 61.1M |
Research & Development | 99.15M | 100.87M | 133.13M | 100.16M | 112.99M | 108.97M | 124.77M | 161.41M | 132.17M | 116.13M | 121.35M | 164.21M | 185.87M | 195.12M | 188.69M | 165.46M | 157.26M | 140.08M | 149.84M | 130.85M | 125.48M | 134.51M |
Other Expenses | 31.76M | n/a | -3.6M | -92.15M | 4.16M | 3.08M | 149.83M | 5.58M | 9.73M | 51.43M | n/a | 60.15M | 136.3M | 41.82M | 75.45M | 31.02M | 11.09M | 11.77M | 4.24M | 25.18M | 13.45M | 11.38M |
Operating Expenses | 211.54M | 187.06M | 230M | 92.05M | 202.41M | 193.01M | 359.28M | 240.45M | 211.4M | 240.83M | 197.64M | 305.25M | 410.62M | 323.85M | 356.86M | 276.6M | 248.25M | 225.12M | 240.63M | 225.28M | 207.81M | 206.99M |
Interest Expense | -48.48M | -49.03M | 55.19M | 32.59M | 30.36M | 34.09M | 41.06M | 41.61M | 43.49M | 40.83M | 44.28M | 28.16M | 29.42M | 27.33M | 24.5M | 20.88M | 21.98M | 23.51M | 22.5M | 21.8M | 22.56M | 19.16M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 226.67M | 246.3M | 207.99M | 213.83M | 205.87M | 375.56M | 251.3M | 226.92M | 255.57M | 303.94M | 314.74M | 423.35M | 338M | 367.75M | 290.61M | 257.89M | 235.26M | 249.96M | 231.82M | 215.17M | 216.09M |
Income Tax Expense | -14.05M | 347K | -4.12M | -38.97M | -6.2M | 63.27M | -28.81M | 8.66M | 13.45M | 6.88M | -1.26M | -33.62M | -38.6M | 3.97M | -18.8M | -17.89M | 3.39M | 4.84M | 4.66M | -36K | 488K | 451K |
Shares Outstanding (Basic) | 83.01M | 82.52M | 80.69M | 81.5M | 78.15M | 78.12M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M | 73.73M | 72.66M | 71.45M | 71.37M | 71.22M | 70.67M | 70.59M | 70.41M | 70.19M |
Shares Outstanding (Diluted) | 92.02M | 82.52M | 80.69M | 87.12M | 78.15M | 86.39M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M | 73.73M | 72.66M | 71.65M | 71.37M | 71.22M | 70.67M | 70.59M | 70.41M | 70.19M |
EPS (Basic) | 1.01 | -0.03 | -1.67 | 0.20 | -0.83 | 11.09 | -0.85 | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 | -2.66 | -1.88 | -2.35 | -1.53 | -2.13 | -1.78 | -2.03 | -1.89 | -1.68 | -1.83 |
EPS (Diluted) | 0.92 | -0.03 | -1.67 | 0.20 | -0.83 | 10.04 | -0.85 | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 | -2.66 | -1.88 | -2.35 | -1.53 | -2.13 | -1.78 | -2.03 | -1.89 | -1.68 | -1.83 |
EBITDA | 148.98M | -36.08M | -70.99M | 20.63M | -33.11M | 971.14M | -46.88M | -49.9M | -35.23M | 11.53M | -32.07M | -73.89M | -157.06M | -64.83M | -126.33M | -68.64M | -97.54M | -72.06M | -97.3M | -95.11M | -80.34M | -95.45M |
EBIT | n/a | -51.49M | -83.9M | 9.52M | -40.69M | 963.92M | -53.64M | -56.38M | -42.24M | -43.86M | -112.78M | -138.43M | -208.06M | -107.66M | -165.19M | -106.33M | -126.72M | -98.38M | -116.11M | -111.86M | -95.32M | -109.03M |
Depreciation & Amortization | n/a | 15.41M | 12.9M | 11.11M | 7.58M | 7.22M | 6.76M | 6.49M | 7.02M | 55.4M | 80.71M | 64.54M | 51.01M | 42.83M | 38.87M | 37.69M | 29.18M | 26.31M | 18.81M | 16.75M | 14.99M | 13.59M |
Add to Watchlist
Select watchlists to add or remove PTCT